Christopher Riley

Christopher Riley is a Senior Product Manager at H1 since August 2022, where responsibilities include building relationships with pharmaceutical clients and executing projects related to disease state landscaping and HCP engagement strategy. Previously, Christopher held roles at ZS, contributing to various life science projects, including clinical trial optimization and commercial launch strategies. Christopher's academic background includes postdoctoral research positions focusing on thermogenic adipose tissue and metabolic syndrome at Dana-Farber Cancer Institute and Harvard Medical School, following a doctoral degree in Biochemistry from The University of Texas at Austin. Additionally, Christopher earned dual undergraduate degrees in Biochemistry and Chemistry from the College of Charleston.